Myelosuppression
Clinical trials for Myelosuppression explained in plain language.
Never miss a new study
Get alerted when new Myelosuppression trials appear
Sign up with your email to follow new studies for Myelosuppression, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to shield bone marrow in tough lung cancer cases
Disease control Recruiting nowThis phase II trial tests whether giving trilaciclib before sacituzumab tirumotecan can protect bone marrow in patients with advanced EGFR-mutated non-small cell lung cancer that has stopped responding to standard treatments. About 49 participants will receive the drug combo and …
Matched conditions: MYELOSUPPRESSION
Phase 2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug aims to shield cancer patients from chemo side effect
Disease control Recruiting nowThis study tests whether a drug called mecapegfilgrastim can safely prevent moderate-to-severe myelosuppression (low blood cell counts) caused by chemotherapy and radiation for lung or esophageal cancer. About 30 adults aged 18-75 will receive the drug alongside their standard ca…
Matched conditions: MYELOSUPPRESSION
Phase 2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a blood test model flag dangerous myelosuppression before it strikes?
Diagnosis Recruiting nowResearchers are evaluating a dynamic risk prediction model for severe myelosuppression in adults with nasopharyngeal carcinoma who receive systemic anticancer treatment. The model estimates the risk of grade 3 or higher anemia, low platelets, or low white blood cells during thera…
Matched conditions: MYELOSUPPRESSION
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC